A path plagued by progression: The chronic kidney disease journey
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
When billed and allowed amounts aren’t enough: HealthVerity proprietary market cost offering in taXonomy
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically,...
How to Target the Right Physicians Using Trigger Programs
As therapies become increasingly complex and personalized, it is imperative that physicians...
The Path Forward: Revealing the Rare Disease Patient Journey
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
Using real-world data to justify coverage for digital health solutions
Today’s most innovative companies are leveraging digital health data solutions to deliver...
The Fight Continues: Battling the COVID Evolution
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
A Ready-Made Solution for Accelerating RSV Research
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
Lessons Learned from COVID-19 Clinical Trials
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Four Steps to Linking Clinical Trial and Real-World Data
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Lab Data in Clinical Research: 4 Powerful Ways to Use It
Lab Data in Clinical Research: 4 Ways It Drives Better Outcomes While most life sciences teams know...
Connecting Data to Contextualize the Complex Diabetes Journey
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...